More tools:Markets·Screener·Research·Chat

Accendra Health, Inc. (ACH) Financial Statements

Accendra Health, Inc.
SIC 5047 · WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES
FIGI BBG001S72KY7
XNYS · usd
1.10▼ 0.11 (-9.09%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close1.21
Day's Range1.08 – 1.24
52-Week Range0.93 – 4.69
Volume768.0K
Avg Volume1.7M
Share Statistics
Shares Outstanding
Employees6,500
ExchangeXNYS
Listed1973-01-02
Share count as of June 30, 2026
Loading Income Statement…
Key questions about Accendra Health, Inc. (ACH)
What is Accendra Health, Inc.'s Market Cap?
Accendra Health, Inc.'s Market Cap is $84.6M, based on as-reported figures from SEC (XBRL) filings.
What is Accendra Health, Inc.'s Enterprise Value?
Accendra Health, Inc.'s Enterprise Value is $1.8B, based on as-reported figures from SEC (XBRL) filings.
What is Accendra Health, Inc.'s Price / Sales?
Accendra Health, Inc.'s Price / Sales is 0.0×, based on as-reported figures from SEC (XBRL) filings.
What is Accendra Health, Inc.'s EV / Revenue?
Accendra Health, Inc.'s EV / Revenue is 0.7×, based on as-reported figures from SEC (XBRL) filings.
What is Accendra Health, Inc.'s EV / EBITDA?
Accendra Health, Inc.'s EV / EBITDA is 6.3×, based on as-reported figures from SEC (XBRL) filings.
What is Accendra Health, Inc.'s Revenue (TTM)?
Accendra Health, Inc.'s Revenue (TTM) is $2.6B, based on as-reported figures from SEC (XBRL) filings.
What is Accendra Health, Inc.'s Net Income (TTM)?
Accendra Health, Inc.'s Net Income (TTM) is -$302.1M, based on as-reported figures from SEC (XBRL) filings.
What is Accendra Health, Inc.'s EBITDA?
Accendra Health, Inc.'s EBITDA is $285.4M, based on as-reported figures from SEC (XBRL) filings.
What is Accendra Health, Inc.'s Diluted EPS (TTM)?
Accendra Health, Inc.'s Diluted EPS (TTM) is -3.93, based on as-reported figures from SEC (XBRL) filings.
What is Accendra Health, Inc.'s EBITDA Margin?
Accendra Health, Inc.'s EBITDA Margin is 10.8%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Condensed Consolidated Statements of Operations
Net revenue
YoY growth-10.1%-6.8%+2.0%+1.5%
Operating costs and expenses:
Cost of net revenue
Selling, general and administrative expenses
Transaction breakage fee——
Acquisition-related charges and intangible amortization
Exit and realignment charges, net
Total operating costs and expenses
Operating loss
% of revenue-5.7%2.7%2.9%3.8%
Interest expense, net
Loss on modification and extinguishment of debt———
Transaction financing fees, net——
Other expense, net
Loss from continuing operations before income taxes
Income tax provision (benefit)
Loss from continuing operations, net of tax
Loss from discontinued operations, net of tax—
Net loss
% of revenue-14.5%-1.0%-7.9%-21.6%
Net loss (in dollars per share)—
Net loss (in dollars per share)—